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Background: Xanthophyllomyces dendrorhous is a basidiomycetous yeast that synthesizes astaxanthin, a carotenoid
with great biotechnological impact. The ergosterol and carotenoid synthetic pathways derive from the mevalonate
pathway and involve cytochrome P450 enzymes. Among these enzymes, the CYP51 family, which is involved in
ergosterol biosynthesis, is one of the most remarkable that has C14-demethylase activity.
Results: In this study, the CYP51 gene from X. dendrorhous was isolated and its function was analyzed. The gene is
composed of ten exons and encodes a predicted 550 amino acid polypeptide that exhibits conserved cytochrome
P450 structural characteristics and shares significant identity with the sterol C14-demethylase from other fungi. The
functionality of this gene was confirmed by heterologous complementation in S. cerevisiae. Furthermore, a CYP51
gene mutation in X. dendrorhous reduced sterol production by approximately 40% and enhanced total carotenoid
production by approximately 90% compared to the wild-type strain after 48 and 120 h of culture, respectively.
Additionally, the CYP51 gene mutation in X. dendrorhous increased HMGR (hydroxy-methylglutaryl-CoA reductase,
involved in the mevalonate pathway) and crtR (cytochrome P450 reductase) transcript levels, which could be associated
with reduced ergosterol production.
Conclusions: These results suggest that the CYP51 gene identified in X. dendrorhous encodes a functional sterol
C14-demethylase that is involved in ergosterol biosynthesis.
Keywords: Cytochrome P450 enzyme systems (P450), Astaxanthin, Sterols, Sterol C14-demethylaseBackground
Xanthophyllomyces dendrorhous is a basidiomycete yeast
that has been mostly studied for its ability to synthesize
xanthophyll astaxanthin as its main carotenoid. Astax-
anthin (3,3’-dihydroxy-β,β-carotene-4-4’-dione) takes third
place in the global market for carotenoids, which reached
$226 million in the year 2010 and is expected to exceed
$250 million by the year 2018 [1]. This carotenoid is cur-
rently used in aquaculture for salmon flesh pigmentation
and as a supplement for the diets of farm chickens to* Correspondence: jalcainog@u.uchile.cl
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unless otherwise stated.produce a stronger yolk and flesh pigmentation [2]. Add-
itionally, astaxanthin has strong antioxidant properties
and has been proposed to play a protective role against
oxidative stress in yeast [3-5]. Recent findings suggested
that astaxanthin supplementation could be beneficial as a
treatment for several degenerative diseases in addition to
other potential benefits for human health [6-9]. To date,
X. dendrorhous is the only known organism that synthe-
sizes astaxanthin from β-carotene through a cytochrome
P450 enzyme system [10-13], suggesting that this yeast
has developed a unique P450 system specialized for the
production of this carotenoid.
Cytochrome P450 proteins (P450s or CYPs) represent
a large superfamily of heme-containing monooxygenaseshis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[14] and play significant roles in the oxidative metabolism
of a wide range of exogenous and endogenous substrates
[15]. CYP enzymes are involved in the biosynthesis of
many physiologically important compounds, such as ste-
rols, steroid hormones, fatty acids and vitamins [16], and a
vast array of secondary metabolites in plants, insects and
fungi [17]. Additionally, these enzymes are the main cata-
lysts involved in the activation and detoxification of differ-
ent xenobiotics, such as drugs, pesticides, carcinogens and
environmentally contaminating chemicals [18]. CYP en-
zymes require the reducing equivalents from NADPH
or NADH, which are generally transferred to CYPs
through a redox partner to catalyze the general reaction
RH +O2 + 2e
− + 2H+→ ROH +H2O [19].
Only two CYP enzymes have been described in X.
dendrorhous: the astaxanthin synthase that is involved
in astaxanthin biosynthesis and CYP61, which partici-
pates in ergosterol biosynthesis [20]. Considering the
biological relevance of this protein family and the in-
volvement of a unique system in X. dendrorhous, in this
work we describe a third CYP in this yeast: CYP51.
CYP51 is one of the first modifying enzymes involved in
sterol synthesis. It catalyzes the C14 demethylation of
lanosterol in yeasts during ergosterol biosynthesis and is
considered to be an ancestral CYP from which other
CYPs evolved [21].
Results and discussion
Cloning and sequence analysis of the X. dendrorhous
CYP51 gene
Using bioinformatic analyses of the genomic and tran-
scriptomic data of X. dendrorhous available in our la-
boratory with the S. cerevisiae ERG11 gene as a query
[GenBank: NM_001179137], we identified a putative X.
dendrorhous CYP51 gene. This gene was uploaded into
the Genbank database [GenBank: KP317478]. The
primers CYP51 up.F and CYP51dw.R were designed
based on this gene sequence and used to amplify gen-
omic DNA from strain UCD 67–385. The obtained
PCR-product of approximately 4,300 bp was inserted
into the EcoRV site of the pBluescript SK- plasmid, gen-
erating plasmid pBS-gCYP51. Similarly, the cDNA ver-
sion (ORF: 1,653 bp) of the CYP51 gene was obtained
by RT-PCR from X. dendrorhous total RNA using the
primer set cCYP51.F + cCYP51.R. This cDNA was li-
gated into the EcoRV site of the pBluescript SK- plasmid
to generate plasmid pBS-cCYP51. The sequences of the
genomic and cDNA versions were determined in both
strands and compared, revealing that the CYP51 gene
from X. dendrorhous consists of 10 exons of 141, 70, 47,
63, 60, 462, 86, 233, 83 and 408 bp and 9 introns of 356,
95, 79, 80, 86, 110, 90, 87 and 90 bp. The CYP51 gene
was predicted to encode a 550 amino acid protein withan expected molecular weight of 61.8 kDa and pI of 6.64.
This protein shares 48% identity and 65% similarity at 91%
coverage with the S. cerevisiae C14-demethylase [ERG11,
Swiss-Prot: P10614] (Figure 1), which belongs to the
cytochrome P450 protein family and is involved in
the third step of ergosterol biosynthesis from squalene:
the conversion of lanosterol to 4,4-dimethylcholesta-
8,14,24-trienol [22,23].
Amino acid sequences are highly diverse among the
cytochrome P450 protein family; however, their structural
fold is highly conserved [24]. In the deduced CYP51
protein from X. dendrorhous, several cytochrome P450
secondary structural elements were predicted using the
CYP450 Engineering database, including alpha helices
A, B, C, E, F, G, H, I, J, K, K’ and L, beta-sheets 1–1,1-2,
1–5, 3–1, 1–4, 2–1, 2–2, 1–3, 3–3, 4–1, 4–2 and 3–2,
the meander loop involved in the stabilization of the ter-
tiary structure and heme binding, and the Cys pocket
that contains the conserved cysteine involved in heme
binding [25] (Figure 1). Identification of P450s across
biological kingdoms depends largely on the identifica-
tion of two P450 signature motifs: ExxR at the K-helix
and FxxGxRxCxG (also known as the CxG motif ) at the
Cys-pocket. These motifs contain three totally conserved
amino acids: the glutamic acid and arginine of the ExxR
motif and the cysteine in the Cys pocket that serves as a
fifth ligand for the heme iron [26]. Site-directed mutagen-
esis of these three invariant residues in most CYPs results
in inactive and misfolded P450 isoforms, suggesting their
importance in maintaining the P450 structure [27,28]. All
of these motifs were recognized in the X. dendrorhous de-
duced CYP51 protein, including the three invariant P450
residues. A threonine and a leucine were found at the sec-
ond and third positions of the ExxR motif; these are the
preferred residues at these positions in P450s, including
the CYP51 family [29]. Moreover, the CxG motif of the X.
dendrorhous CYP51 protein (FGAGRHRCIG) maintains
the preferred residues described for the CYP51 family
[29]. This finding is interesting because instead of the con-
served arginine at the sixth position of this motif, CYP51
contains a histidine surrounded by arginines. Additionally,
a putative hydrophobic trans-membrane segment at the
CYP51 amino terminus was predicted. This finding repre-
sents an important feature that allows class II P450 en-
zymes to anchor to the endoplasmic reticulum [30]. These
observations strongly suggest that the identified X.
dendrorhous gene encodes a cytochrome P450 enzyme,
specifically CYP51 with lanosterol demethylase activity.
The deduced X. dendrorhous CYP51 protein was mod-
eled (Figure 2A) with the homology modeling technique
using the SwissModel web server. The S. cerevisiae
ERG11 protein [PDB: 4 lxj.1], which shares 48% se-
quence identity, was used as a template. Additionally,
possible protein-ligand binding interactions between the
Figure 1 Sequence alignment between X. dendrorhous CYP51 and S. cerevisiae ERG11 proteins and prediction of structurally conserved motifs in
CYP51. Amino acid alignment between the deduced CYP51 sequence from X. dendrorhous (Xd) strain UCD 67–385 and the S. cerevisiae (Sc) strain
S288c ERG11 (lanosterol C14-demethylase) protein [Swiss Protein: P10614]. Amino acid differences with the same properties are denoted with a
plus (+). Structural elements are highlighted with the name of the corresponding feature above them: possible transmembrane helix (underlined
and italics), alpha helices (red and italics), beta-sheets (blue and italics), meander loop and Cys pocket (white highlighted in black). The asterisks
(*) indicate the three totally conserved amino acids among cytochromes P450. Secondary structural elements were predicted with the CYP450
Engineering database [26], and the potential transmembrane region was predicted with TMpred [52].
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itraconazole ligands were predicted with the protein
docking technique using the AutoDock4 program [31]
(Figure 2B). According to the results, the azole antifungal
fits in a similar way to the substrate lanosterol in a
hydrophobic groove and interacts with Met-315 and the
P-methyl group of Thr-322. Previous studies have also
reported these residues as binding sites of azole antifun-
gals in cytochrome P450 proteins [32]. Therefore, the
itraconazole azole binds to the CYP51 protein in the
substrate-binding pocket of the enzyme, thus blocking
its enzymatic catalysis.Functional analysis of the X. dendrorhous CYP51 gene
The functionality of the X. dendrorhous CYP51 gene was
evaluated by two different approaches: heterologous
complementation in S. cerevisiae and gene mutation in
X. dendrorhous.
The heterologous complementation analyses were per-
formed using a diploid S. cerevisiae that is heterologous
for the ERG11 gene (Sc-erg11+/− strain), because a null
mutant is not viable [33]. The S. cerevisiae ERG11 gene
and the cDNA of the X. dendrorhous CYP51 gene were li-
gated into the S. cerevisiae expression vector YEpNP, gen-
erating plasmids YEpNP-gERG11 and YEpNP-cCYP51;
Figure 2 Three-dimensional model and docking of the X. dendrorhous
CYP51 deduced protein. (A) The model was generated by the
SwissModel web server [54] using the S. cerevisiae ERG11 protein
with lanosterol as the template ligand (model code. 4 lxj.1).
(B) The AutoDock4 program [31] was used to perform automated
docking to predict the binding sites of lanosterol (red) and
itraconazole (blue) in the obtained model of the CYP51
protein from X. dendrorhous.
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strain. Several transformants were recovered in each case,
and at least three transformants of each type were randomly
chosen to confirm that they contained the respective
plasmid. Given that all of the analyzed transformants
showed a positive result in this analysis, one of each
(named Sc-gERG11Sc and Sc-cCYP51Xd, respectively)
was chosen for sporulation to obtain haploid strains.
After 6 days of incubation in sporulation media agar
plates, the formation of asci was confirmed by optical
microscopy. The asci were broken and seeded onto SD
agar plates supplemented with G418 to confirm the
presence of the S. cerevisiae ERG11 mutant allele, and
with uracil, histidine, lysine and methionine to sustain
all possible auxotrophies in the resulting haploid strains.
Although the haploid cells were enriched by diethyl
ether treatment [34], it is also possible to obtain diploid
strains among the G418-resistant strains. Because of
this, haploid strains were first selected according to
their auxotrophy for methionine and lysine, both of
which are heterozygous markers in the original diploid
parental strain. Subsequently, the haploid condition of
the ERG11 mutant allele and its complementation of
the expression vector were confirmed by PCR analyses
using comprehensive sets of primers (Figure 3). After
these analyses, a single strain that fulfilled the require-
ments for heterologous expression studies carrying the
YEpNP-gERG11 or the YEpNP-cCYP51 vector was chosen;
these strains were named Sc-hERG11 and Sc-hCYP51,
respectively.
The strains Sc-hERG11 and Sc-hCYP51 did not show
significant differences in their growth curves when cul-
tured in YM medium at 22°C with constant agitation(Additional file 1: Figure S1). Additionally, sterols were
extracted after 10, 24 and 56 h of cultivation (Table 1).
When the sterol compositions were analyzed by RP-
HPLC, all strains showed the same sterol pattern, with
one main sterol produced with 13 min of retention time.
This sterol was confirmed to correspond to ergosterol
after co-injecting each sample with standard ergosterol.
In general, strain Sc-hCYP51 showed a lower sterol content
than strains Sc-erg11+/− and Sc-hERG11 at all analyzed time
points. However, the fact that strain Sc-hCYP51 was viable
and able to produce ergosterol indicates that the CYP51
gene from X. dendrorhous complements the erg11 null
mutation in S. cerevisiae. Therefore, this gene encodes a
lanosterol C14-demethylase that is able to couple with
the endogenous S. cerevisiae cytochrome P450 reduc-
tase in vivo.
To evaluate the functionality of CYP51 in X. dendrorhous,
cyp51 mutants were created by replacing the CYP51 locus
with an antibiotic resistance module through homologous
recombination as previously described [35]. For this pur-
pose, the wild-type strain CBS 6938 was chosen because it
has been shown to be aneuploid, and hemizygous mutants
can be obtained after only one transformation event [12].
Before transformation, the CYP51 gene from strain CBS
6938 was sequenced, uploaded to the Genbank database
[Genbank: KP317479] and compared to the sequence from
strain UCD 67–385. Minimal differences were found be-
tween these two strains, which possessed 99.707% identity
in the region from the start to the stop translation codons.
After CBS 6938 transformation with linear plasmid pBS-
cyp51/hph, a hygromycin B-resistant transformant was ob-
tained. Although it was confirmed that the CYP51 locus
was indeed replaced by the resistance module in this strain,
the CYP51 gene could still be amplified using a compre-
hensive set of primers, suggesting that this strain was
heterozygous for the CYP51 locus. Therefore, this strain
was named CBS-CYP51+/−. This strain was still a useful
model to evaluate the effect of the CYP51 mutation in
X. dendrorhous; because the deletion of this gene has
been shown to be lethal to the cells of other yeast
strains, a cyp51 null mutant would most likely not be vi-
able [36]. Interestingly, the mutant strain had a more in-
tense reddish color that was discernable to the naked
eye than the wild type strain, suggesting that it produces
more carotenoids than the parental strain. To confirm
this observation and to evaluate phenotypic variations
between these two strains, growth curves were constructed
and sterols and carotenoids were extracted and quantified
after 48 and 120 h of cultivation.
The growth curves of both strains did not show sig-
nificant differences at the lag and exponential phases of
growth; however, strain CBS-CYP51+/− reached a lower
OD600 during the stationary phase of growth (P-value <





Figure 3 PCR-based analyses of S. cerevisiae erg11− strains carrying the YEpNP-gERG11 and YEpNP-cCYP51 vectors. PCR analyses to confirm the
presence of the kanMX gene at the ERG11 locus (panel A: primers CYP51ScExt.F and KanMX4.R2 and panel B: primers KanMX4.F2 and
CYP51ScExt.R), the presence of the X. dendrorhous CYP51 gene (panel C: primers RTCYP51.F and CYP51.Rb), the presence of the ERG11 gene
(panel D: gERG11.F and gERG11.R) and the absence of the ERG11 gene in the S. cerevisiae genome (panel E: gERG11.F and CYP51ScExt.R).
Template DNA in each lane: S. cerevisiae parental diploid strain erg11 +/− (Lane 1), S. cerevisiae S288c strain (Lane 2), S. cerevisiae Sc-hCYP51 strain
(Lane 3), S. cerevisiae Sc-hERG11 strain (Lane 4), X. dendrorhous UCD 67–385 strain (Lane 5), negative control without DNA (Lane 6). Molecular size
marker Lambda/Hind III (Lane M: 23.1, 9.4, 6.6, 4.4, 2.3, 2.0 and 0.6 kb). A schematic diagram is included to represent the primer sets (shown in
arrows) that were used. The UP and DOWN regions correspond to regions located 300 bp upstream and downstream of the S. cerevisiae ERG11
gene, respectively. Region KanMX4 corresponds to the geneticin (G418) resistance module and the pACT4 and tTDH3 regions correspond to the
S. cerevisiae promoter and terminator region in YEpNP.
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proximately 70% more sterols than the mutant strain;
however, after 120 h of culture, there were no statisti-
cally significant differences between the strains (Table 2).
This outcome may be the result of a regulation mechan-
ism that modulates sterol biosynthesis according to the
metabolic state of the yeast, which is reduced during the
stationary phase of growth. Similarly, previous studies infilamentous fungi and in yeast have reported reduced er-
gosterol accumulation during the stationary phase of
growth [20,37]. Moreover, both strains showed the same
sterol composition, with ergosterol representing close to
100% of the identified sterols; this result was confirmed
by co-injection of the samples with standard ergosterol
in RP-HPLC analysis. An additional two unidentified ste-
rols could be detected in both strains with retention
Table 1 Sterols obtained from S. cerevisiae strains used in this study (mg per g of dry yeast)
S. cerevisiae strains
(Sc-erg11+/−) Sc-hERG11 Sc-hCYP51
Cultivation Time (h) 10 24 56 10 24 56 10 24 56
Total sterols 25 ± 5 11 ± 1 21 ± 3 21 ± 8 16 ± 5 38 ± 7 19 ± 3 9 ± 1 20 ± 2
Ergosterol (11 min) 23 ± 5 10 ± 1 20 ± 2 17 ± 2 15 ± 4 34 ± 6 16 ± 3 9 ± 3 18 ± 2
Peak 2 (12.5 min) ND 0.03 ± 0.02 0.2 ± 0.3 ND 0.06 ± 0.02 0.4 ± 0.4 ND ND 0.21 ± 0.04
Peak 3 (15 min) 3 ± 1 0.7 ± 0.1 1.45 ± 0.03 4 ± 1 1.5 ± 0.4 3.1 ± 0.4 2.4 ± 0.6 0.7 ± 0.1 1.6 ± 0.1
ND: Not detected. Table values correspond to the average result from three independent cultures ± standard deviations. The RP-HPLC retention time is indicated
in parenthesis.
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found in a significantly lower proportion.
The mutant strain contained a higher amount of carot-
enoids (P-value < 0.05, Student's t test), with an approxi-
mately 1.9-fold increase after 120 h of culture. Previous
studies on carotenogenesis in X. dendrorhous have shown
that this process is induced by the end of the exponential
and early stationary phases of growth, coinciding with the
point at which glucose is completely exhausted [38-40].
Therefore, it is expected that the major differences in
carotenoid content can be better appreciated in older cul-
tures. However, the CBS-CYP51+/− strain also had a higher
carotenoid content after 48 h of culture, suggesting that
carotenogenesis starts earlier in this strain. Moreover,
carotenoid composition also differed between both
strains, with a reduced astaxanthin proportion in the
CBS-CYP51+/− strain (Table 2). Interestingly, changes
in the carotenoid composition showed similarity to
cultures of X. dendrorhous in which the crtI gene (encod-
ing the phytoene desaturase) was over-expressed [41],
resulting in an increased monocyclic carotenoid propor-
tion in CBS-CYP51+/− cells. Moreover, β-carotene and
xanthophyll intermediaries such as phoenicoxanthin and




Cultivation Time (h) 48 120
Sterols: 5.6 ± 0.2 3.8 ±
Total Carotenoids: 24 ± 5 (100) 256
Astaxanthin 19 ± 4 (78) 174
Phoenicoxanthin 2.5 ± 0.7(10) 30.0
Canthaxanthin ND ND
Echinenone ND ND
β-carotene ND 12 ±
Lycopene ND ND
Monocyclic carotenoids 2.8 ± 0.8 (11) 40 ±
ND: Not detected. Table values correspond to the average result from three indepe
indicated in parenthesis. Monocyclic carotenoids include: γ-carotene, keto-γ-carotenastaxanthin from β-carotene in CBS-CYP51+/−, sug-
gesting that the cytochrome P450 system involved in
these steps may be weakened. It is likely that this
change is the consequence of the reduced CYP51 gene
dose in CBS-CYP51+/−, which could favor the activity
of the cytochrome P450 systems involved in ergosterol
biosynthesis at the expense of astaxanthin synthesis.
This idea is supported by the higher cytochrome P450
reductase transcript levels found in the CBS-CYP51+/−strain
after 24 h of cultivation (see below) that can sustain
cytochrome P450 activity during ergosterol biosynthesis.
Similar to our findings, several studies have observed
increased carotenoid production in X. dendrorhous when
ergosterol levels are reduced. For example, when Phaffia
rhodozyma (the anamorphic state of X. dendrorhous)
was cultured in the presence of the antifungal ergosterol
biosynthesis inhibitor fluconazole, enhanced astaxanthin
production was observed [42]. One possible explanation
is that ergosterol down-regulates its own synthesis via a
negative-feedback mechanism. Therefore, a reduced er-
gosterol content favors the availability of mevalonate
pathway products, which are common to ergosterol and
carotenoid syntheses. This reasoning is supported by a
previous study in which X. dendrorhous mutants that areer g of dry yeast) obtained from the X. dendrorhous used
CBS-CYP51+/−
48 120
0.4 3.2 ± 0.7 4.9 ± 0.8
± 18 (100) 325 ± 115 (100) 486 ± 54 (100)
± 23 (68) 95 ± 27 (29) 203 ± 20 (42)
± 0.8 (12) 37 ± 15 (11) 74 ± 14 (15)
9 ± 5 (3) 12 ± 6 (3)
4 ± 7 (1) ND
6 (5) 67 ± 33 (21) 55 ± 15 (11)
7 ± 6 (2) ND
3 (16) 107 ± 40 (33) 149 ± 27 (31)
ndent cultures ± standard deviations. Percentage relative to total carotenoids is
e, hydroxy-keto-γ-carotene, torulene and hydroxy-keto-torulene.
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tion had increased carotenoid content compared to their
parental wild type strains. Moreover, transcript levels of
at least one gene of the mevalonate pathway (HMGR
that encodes the hydroxymethylglutaryl CoA-reductase)
were significantly increased [20]. In this sense, the sup-
plementation of mevalonate in P. rhodozyma cultures
resulted in an increase in carotenoid production [43].
Furthermore, deletion of the gene encoding squalene
synthase (ERG9, the first step of sterol biosynthesis per
se) in combination with the overexpression of the cata-
lytic domain of the hydroxymethylglutaryl CoA-reductase
in a recombinant Candida utilis strain caused an increase
in lycopene production [44].
Based on this reasoning, we evaluated whether HMGR
transcript levels were enhanced in strain CBS-CYP51+/−.
To accomplish this, total RNA was extracted from the
parental and CBS-CYP51+/− strains after 24 and 48 h of
cultivation in YM media with constant agitation at 22°C,
and the transcript levels were analyzed by RT-qPCR.
The results revealed that the HMGR transcript level was
indeed higher in the mutant strain compared to the
wild-type strain, indicating that the elimination of one
allele of the CYP51 gene of X. dendrorhous affected the
expression of HMGR (Figure 4A). The HMGR gene con-
trols one of the key regulatory steps in the mevalonate
pathway, and, in turn, carotenoid and ergosterol biosyn-
thesis through substrate availability [45]; therefore, an
increase in the HMGR transcript level could partly ex-
plain the increased carotenoid content in the mutant
strain CBS-CYP51+/−. Similar to our findings, there was
an increase in carotenoid content that was also related
to a higher HMGR transcript levels following the treat-
ment of the fungus Blaskelea trispora with ketoconazole,
a specific inhibitor of CYP51 [46].A B
Figure 4 RT-qPCR analysis of the HMGR, crtR and CYP51 genes in the wild-
transcript levels were determined by RT-qPCR after 24 and 48 h of cultivati
was normalized with respect to the transcript level of the actin gene and t
CBS-CYP51+/− (gray bars). Values are the mean ± standard error of three indBecause cytochrome P450 enzymes are involved in
both astaxanthin and ergosterol biosynthesis, we also
evaluated the crtR transcript levels [12]. crtR encodes for
a cytochrome P450 reductase, which is the main elec-
tron donor in these systems. Interestingly, the crtR tran-
script level was also higher in CBS-CYP51+/− after 24 h
of cultivation; however, this difference was not statistically
significant after 48 h of growth (Figure 4B). Although
several different genes may encode cytochrome P450
enzymes in an organism, usually there is only one gene
encoding the enzyme cytochrome P450 reductase. Con-
sequently, a complex mechanism of regulation of the ex-
pression of crtR is required to set the levels of cytochrome
P450 reductase activity in relation to the various cyto-
chrome P450 proteins in this organism. To date, three
cytochrome P450-encoding genes have been described in
X. dendrorhous: crtS [10], CYP61 [20] and CYP51 [this
current work]). Thus, the cytochrome P450 reductase
would act as a cytochrome P450 redox partner at least in
the carotenoid and ergosterol synthesis pathways. Finally,
we also analyzed whether the elimination of one CYP51
allele indeed affected its own transcript levels. After 24 h
of cultivation, no significant differences were observed be-
tween the mutant and the parental strain; however, after
48 h of cultivation, differences could be appreciated
(Figure 4C), confirming that the X. dendrorhousmutant gen-
erated in this work indeed affected CYP51 transcript levels.
Conclusions
In this work, the CYP51 gene from X. dendrorhous was
identified and its function was characterized. This gene
encodes a putative protein that contains all of the cyto-
chrome P450 conserved motifs and is consistent with
CYP51 protein family characteristics. The heterologous
complementation analysis in S. cerevisiae strongly suggestsC
type and CBS-CYP51+/− strains. The HMGR (A), crtR (B) and CYP51 (C)
on of the wild-type and the CBS-CYP51+/−strains. Each transcript level
hen with respect to the wild-type strain: CBS 6938 (=1, black bars) and
ependent experiments (* p≤ 0.05; Student’s t test).
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demethylase. Moreover, a CYP51 mutation in X. dendror-
hous affected sterol and carotenoid production, supporting
the finding that reduced sterol production is related to
higher carotenoid production.
Methods
Biological material and microorganism culture conditions
Restriction enzymes, the Klenow polymerase and the M-
MLV reverse transcriptase were purchased from Promega,
and the Pfu DNA polymerase was purchased from Invitro-
gen. The plasmids and microbial strains that were used
and constructed for this work are included in Table 3. The
wild type UCD 67–385 (ATCC 24230) X. dendrorhous
strain was used for genome and transcriptome sequencing
and for genomic and cDNA CYP51 gene amplificationTable 3 Plasmids and strains used and constructed in this stu
Relevant features or strain genotype
Plasmids:
pBluescript SK- (pBS) ColE1 ori; AmpR; cloning vector with blu
pMN-hph pBS containing at the EcoRV site a casse
(hph) gene under EF-1 α promoter and G
pBS-gCYP51 pBS bearing the genomic version of the
pBS-cCYP51 pBS bearing the ORF of the CYP51 gene
pBS-cyp51/hph pBS bearing the hygromycin B resistance
and 600 pb downstream of the X. dendr
YEp-Act4 pBR322 and 2 micron ori, AmpR, LEU2 an
expression.
YEpNP YEp-Act4 bearing the S. cerevisiae TDH3 t
YEpNP-cCYP51 YEpNP bearing the X. dendrorhous CYP51
promoter and the TDH3 terminator.
YEpNP-gERG11 YEpNP bearing the S. cerevisiae ERG11 ge
and the TDH3 terminator.
Strains:
E. coli:
DH-5α F- φ80d lacZΔM15Δ (lacZY-argF) U169 d
gyrA96 relA1
S. cerevisiae:
S288c MATα, SUC2, gal2, mal, mel, flo1, flo8-1,
Meyen ex E.C Hansen YHR007C
BY4743 (Sc-erg11+/−)
MATa/MATα, his3Δ1/ his3Δ1, leu2Δ0/leu
ΔERG11:KanMx. ATCC 26604.
Sc-cCYP51Xd Diploid transformant derived from Sc-erg
Sc-gERG11Sc Diploid transformant derived from Sc-erg
Sc-hCYP51 Sporulation product derived from Sc-erg
Sc-hERG11 Sporulation product derived from Sc-erg
X. dendrorhous:
UCD 67-385 ATCC 24230, wild-type.
CBS 6938 ATCC 96594, wild-type.
CBS-CYP51+/− (CBS-CYP51/cyp51hph). Transformant deriv
locus replaced by a hygromycin B resistaand isolation. For the CYP51 gene mutation, the wild type
CBS 6938 (ATCC 96594) X. dendrorhous strain was used.
Escherichia coli DH-5α was used as a host for plasmid
propagation. Saccharomyces cerevisiaeMeyen ex E.C Hansen
YHR007C BY4743 (ATCC 26604) was used for CYP51
heterologous complementation analysis because it is a
diploid and heterozygous mutant for the ERG11 gene
(erg11(+/−)), with one copy of ERG11 replaced by a ge-
neticin resistance cassette. Most plasmid constructs de-
rived from pBluescript SK- [47]. Plasmid YEpNP was
modified from YEpACT4 [48] and used for S. cerevisiae
heterologous complementation.
X. dendrorhous was cultured in YM rich medium (1%
glucose, 0.3% yeast extract, 0.3% malt extract and 0.5%
peptone) with constant agitation at 22°C. For transfor-




tte of 1.8 kb bearing the E. coli-Hygromycin B resistance
PD transcription terminator of X. dendrorhous.
[56]
CYP51 gene from X. dendrorhous (4,318 bp). This work
from X. dendrorhous (1,653 bp). This work
cassette flanked by approximately 700 bp upstream
orhous CYP51 locus.
This work
d containing the ACT promoter to regulate gene [48]
erminator. This work
cDNA (1,653 bp) under the regulation of the ACT This work
ne (1,593 bp) under the regulation of the ACT promoter This work
eoR recA1 endA1 hsdR17(rk- mk+) phoA supE44 l- thi-1 [47]
hap1, ho, bio1, bio6. [64]
2Δ0, lys2Δ0/+, met15Δ0/+, ura3Δ0/ura3Δ0, ATCC 26604
11+/− containing the expression vector YEpNP-cCYP51. This work
11+/− containing the expression vector YEpNP-gERG11. This work
11+/− containing the expression vector YEpNP- cCYP51. This work
11+/− containing the expression vector YEpNP-gERG11. This work
ATCC 24230
ATCC 96594
ed from CBS 6938 containing an allele of the CYP51
nce module.
This work
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Biological).
E. coli was cultured at 37°C with constant agitation in
Luria-Bertani (LB, 1% tryptone, 0.5% yeast extract, and
0.5% NaCl) medium and on 1.5% agar LB plates supple-
mented with 100 μg/ml ampicillin for plasmid selection
and 20 μg/ml of X-gal (5-bromo-4chloro-3-indolyl-β-D-
galactopyranoside) for recombinant clone selection by
blue-white screening [47]. For selection, recombinant
clones bearing the constructed plasmids were analyzed
by direct colony PCR with an adequate set of primers.
S. cerevisiae strains were cultured at 30°C in YM or
YEP (YM: 0.3% yeast extract, 0.3% malt extract and 0.5%
peptone; YEP: 2% glucose, 1% yeast extract, and 2%
peptone) rich media. The strain Meyen ex E.C Hansen
YHR007C BY4743 was cultured at 22°C in SD medium
(0.67% yeast nitrogen base without amino acids and 2%
glucose) supplemented with metabolites to sustain the
strain auxotrophy (0.002% uracil, 1% histidine and 1%
leucine) and 200 μg/ml of geneticin. Transformants
derived from this strain were cultured in SD medium
supplemented with uracil, histidine and geneticin, be-
cause the vector YEpNP complements the parental
strain’s leucine auxotrophy.
Nucleic acid extraction, DNA amplification and
sequence analysis
X. dendrorhous DNA extraction was performed from
protoplasts according to [49], and total RNA extraction
was performed according to a modified protocol of
Chomczynski and Sacchi [50] for X. dendrorhous [38].
Total RNA was quantified spectrophotometrically at
260 nm according to [47] in a V-630 UV–vis Spectro-
photometer (JASCO). S. cerevisiae genomic DNA was
obtained by mechanical cell disruption using 0.5 mm
glass beads (BioSpec) and shaking in a mini bead
beater-16 (BioSpec). Plasmid DNA was obtained from
E. coli strains using the AxyPrep Plasmid Miniprep kit
(Axygene).
Oligonucleotides designed and used in this work were
synthesized by Integrated DNA Technologies and are
listed in Additional file 2: Table S1. PCR reactions were
performed in a final volume of 25 μl with 2 U of Taq
DNA polymerase, 2.5 μl of 10X Taq buffer, 0.5 μl of
10 mM dNTPs, 1 μl of 50 mM MgCl2, 1 μl of each primer
(25 μM) and 10 to 20 ng of template DNA in an Applied
Biosystems 2720 thermal cycler. The general amplification
protocol was as follows: initial denaturation at 95°C for
3 min; 35 cycles of denaturation at 94°C for 30 s, an-
nealing at 55°C for 30 s, and synthesis at 72°C for 3 min;
and a final extension step at 72°C for 10 min. Samples
were stored at 4°C until analyzed by 0.8% agarose gel
electrophoresis in TAE buffer stained with 0.5 μg/ml
ethidium bromide [47]. DNA for sequencing or plasmidconstruction was purified from gels by the glass milk
method [51].
DNA sequencing was performed in an ABI 3100
Avant genetic analyzer using the BigDye terminator
v3.1 kit (Applied Biosystems) and analyzed with
Vector NTI Suite 10 (Informax), CLUSTAL W 1.8
and programs available at the NCBI web site. Protein
sequence analyses were performed with programs avail-
able at www.ch.embnet.org/software/TMPRED_form.html
[52], www.ebi.ac.uk/InterProScan/ [53] and www.cyped.uni-
stuttgart.de/ [25].
Protein modeling was performed using programs
available at www.swissmodel.expasy.org/ [54], http://
autodock.scripps.edu/wiki/AutoDock4 [31] and www.
ks.uiuc.edu/Research/vmd/ [55].
Isolation of the X. dendrorhous CYP51 gene and plasmid
construction
To identify the CYP51 gene from X. dendrorhous,
BLAST analyses using homologous CYP51 nucleotide
and amino acid sequences were performed with the
yeast genomic and transcriptomic databases available
in our laboratory [20]. Specific primers were designed
from the identified sequences (Additional file 2: Table S1).
For the S. cerevisiae heterologous complementation
experiments, the CYP51 cDNA from X. dendrorhous
and the ERG11 gene from S. cerevisiae (homologous to
CYP51) were ligated into the yeast expression plasmid
YEpNP (Table 3). First, plasmid pBS-cCyp51, which
contained the cDNA of the CYP51 gene, was con-
structed by inserting a 1,653 bp RT-PCR product into
the EcoRV site of plasmid pBluescript SK-, which was
obtained using the primer set cCYP51.F + cCYP51.R
(Additional file 2: Table S1). Plasmid pBS-cyp51/Hyg
was used to eliminate an allele of the CYP51 gene in X.
dendrorhous. This plasmid was obtained by sequentially
joining three DNA fragments: i) 700 bp (amplified with
primers CYP51_del.Fw + CYP51_del-HpaI.Rv) upstream
of the CYP51 gene encoding sequence; ii) the hygromycin
B resistance module [56] (amplified with primers H.F and
H.R); and iii) 600 bp (amplified with primers CYP51_del-
HpaI.Fw + CYP51_del.Rv) downstream of the CYP51 gene
encoding sequence. These sequences were inserted into
the EcoRV site of plasmid pBluescript SK-. For X. dendror-
hous transformation, the insert of plasmid pBS-cyp51/Hyg
was released using the NotI and XhoI endonucleases.
Yeast transformation
S. cerevisiae electrocompetent cells were prepared from
60 ml of exponentially growing cultures in YEP medium
at 22°C with constant agitation. The cells were washed
three times with chilled sterile distilled water, one time
with sorbitol 1 M and finally suspended in 0.2 ml of 1 M
sorbitol. The cells were kept at 4°C, and 40 μl aliquots
Leiva et al. BMC Microbiology  (2015) 15:89 Page 10 of 12were used for electroporation with a BioRad gene
pulser × cell with PC and CE modules under the following
conditions: 1.5 kV, 25 μF and 200 Ω. X. dendrorhous
transformation was also performed by electroporation
according to [57] and [58] using 1 to 5 μg of linear
donor DNA. Electrocompetent cells were prepared from
exponential cultures, grown in YM medium and electropo-
rated using the following program: 125 mF, 600Ω, 0.45 kV.
S. cerevisiae heterologous complementation assay
The erg11(+/−) S. cerevisiae strain, which is diploid and
heterozygous for the ERG11 gene, was used for the gene
complementation assays. The S. cerevisiae ERG11 gene
and the X. dendrorhous CYP51 gene were ligated into
plasmid YEpNP and used to independently transform
the original diploid yeast strain. Transformants were se-
lected in SD agar plates supplemented with 200 μg/ml
geneticin, 0.002% uracil and 1% histidine according to
the parental strain requirements. Transformant strains
were randomly chosen and incubated in pre-sporulation
medium plates (0.8% yeast extract, 0.3% peptone, 10%
glucose and 2% agar), incubated at 22°C for 1 to 2 days
and then transferred to minimal sporulation medium
plates (1% potassium acetate and 2% agar) for incubation
at 22°C for 3 to 6 days. Supplements according to the
parental strain genotype were added to the sporulation
media. Asci formation was confirmed by optical micros-
copy. To enrich the asci fraction, cells were collected
from the sporulation plates, treated with diethyl ether
for 20 min at 22°C [34] and the ascospores were released
by treatment with zimoliase-120 T (US Biological) at 30°
C for 2 h. Afterwards, the mixture was shaken in a mini
bead beater-16 (BioSpec) with 0.5 mm glass beads
(BioSpec) for 2 min [59]. Finally, the cells were spread
on SD agar plates supplemented with histidine, uracil,
lysine, methionine and geneticin to support all possible
combinations of auxotrophies in the resulting haploid cells.
To select the desired haploid cells to study gene com-
plementation, the obtained colonies were streaked in
replicates on SD agar plates supplemented with genet-
icin and: i) uracil, histidine and lysine, ii) uracil, histidine
and methionine and iii) uracil, histidine, methionine and
lysine. Colonies that developed on the plates supple-
mented with the four metabolites but not when lysine or
methionine were omitted were chosen for further analyses.
Sterol and carotenoid extraction and analysis
Sterols were extracted from both the S. cerevisiae and X.
dendrorhous strains, while carotenoids were extracted
only from X. dendrorhous. Metabolites were spectro-
photometrically quantified and normalized to the dry
weight of the yeast.
Sterols were extracted according to the protocol of
[60] by mixing cell pellets with 4 g of KOH and 16 ml of60% (v/v) ethanol/water and incubating at 80 ± 2°C for
2 h. Then, non-saponificable sterols were extracted with
10 ml of petroleum ether and quantified spectrophoto-
metrically at 280 nm. Carotenoids were extracted from
cellular pellets by the acetone method [61] and quanti-
fied spectrophotometrically at 465 nm. Sterol and carot-
enoid compositions were analyzed by RP-HPLC with an
RP-18 Lichrocart125-4 (Merck) column using methanol:
water (97: 3, v/v) or acetonitrile: methanol: isopropanol
(85: 10: 5, v/v) as the mobile phase with a 1 ml/min flux
under isocratic conditions to separate the sterols and ca-
rotenoids, respectively. The elution spectra were recov-
ered using a diode array detector, and the metabolites
were identified according to their spectra and retention
time in comparison to standards.
Single-strand DNA synthesis and RT-qPCR
Single-stranded DNA was synthesized according to the
M-MLV reverse transcriptase (Invitrogen) manufacturer’s
instructions using 5 μg of total RNA in a final volume of
20 μl. Relative gene expression levels were obtained in an
Mx3000P quantitative PCR system (Stratagene) using 1 μl
of the reverse transcription reaction, 0.25 μM of each pri-
mer and 10 μl of the SensiMix SYBR Green I (Quantace)
kit in a final volume of 20 μl. The Ct values obtained were
normalized to the corresponding value for the beta-actin
encoding gene [Genbank: X89898.1] [62], and later
expressed as a function of the control conditions using
the ΔΔCt algorithm [63].
Additional files
Additional file 1: Figure S1. Growth curves of yeast strains used in this
study. (A) S. cerevisiae strains Sc-erg11+/−, Sc-hERG11 and Sc-hCYP51 were
cultured in YM media at 22°C with constant agitation. (B) Growth curve
of the X. dendrorhous CBS 6938 and CBS-CYP51+/− strains cultured in YM
media at 22°C with constant agitation. Values are the mean ± standard
error of three independent cultures.
Additional file 2: Table S1. Primers designed and used in this study.
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